Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
Despite much interest in expanding chemical space, diverse, billion molecule libraries remain inaccessible. In
principle, docking a virtual library could access some of this missing chemical space. This idea has until now
been vitiated by two key problems: 1. prediction of readily synthesized molecules has been challenging, without
resorting to strategies that collapse diversity; and 2. docking is notoriously inaccurate. Two recent advances
have made virtual library docking screens seem less fanciful. First, our collaborators at Enamine, a widely used
fine chemicals supplier, have defined a 0.7 billion molecule make-on-demand library based on >100 reactions
that they have under good control; >650,000 of these have been successfully synthesized. Second, while
docking retains serious errors, it has made pragmatic progress, and has found genuinely novel ligands for >100
targets. The specific aims are:
Aim 1. A robust, searchable, and dockable database of 3 billion diverse lead-like molecules. We will A.
Enumerate 3 billion vetted products from two- and three-component reactions. B. measure the diversity and
novelty of this library and how they differ from the world's in-stock molecules. C. Develop a community accessible
database and chemoinformatics infrastructure that can store, similarity search, and rapidly retrieve molecules
from this library. D. convert these molecules into biologically relevant 3D forms, including enumerating low-
energy conformers, partial atomic charges and other parameters, van der Waals parameters and solvation
energies for all library molecules, enabling their use for docking screens.
Aim 2. Dock and experimentally test the library against two targets. A. Screen the library against the dopamine
D4 and kappa-opioid receptors, seeking novel ligands. 250 to 500 library molecules will be tested per screen,
itself a 10-fold increase. A key question will be do we find novel, potent ligands, or are we overwhelmed by false
positives? B. As the library grows, do we continue to find ever more novel, in some sense ever more perfect,
high affinity ligands, or does discovery saturate? C. How does hit rate vary with docking score? As we will be
testing hundreds of molecules, we can afford to investigate not only those with the highest docking ranks, but
also molecules with mediocre and poor ranks. This has not been previously explored, certainly not at scale.
If successful, this project will increase the number of molecules available to the community by 1000-fold, and
demonstrate their utility for ligand discovery. Extensive preliminary results support its feasibility.
Public Health Relevance Statement
PROJECT NARRATIVE
This proposal develops a method to discover new-to-the-planet small molecules to modulate biology. It
leverages recent innovations in low-cost chemical synthesis and molecular docking methods to screen orders
of magnitude more chemicals in the computer, testing these predictions against two important targets - opioid
and dopamine receptors. A practical outcome is new tools useful to the community to enable them to find new
compounds for their own targets.
No Sub Projects information available for 5R01GM133836-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM133836-02
Patents
No Patents information available for 5R01GM133836-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM133836-02
Clinical Studies
No Clinical Studies information available for 5R01GM133836-02
News and More
Related News Releases
No news release information available for 5R01GM133836-02
History
No Historical information available for 5R01GM133836-02
Similar Projects
No Similar Projects information available for 5R01GM133836-02